Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Hematology | Devices
Disease Category: Hemodialysis
Location: United States, NY

Clinical Trial Details

Overview

Research Study Summary

End-stage Renal Disease Hemodialysis

Purpose

The purpose of this study is to test a new liquid drug (during the dialysis procedure) containing iron that may help maintain your iron storage ability for people who are on chronic hemodialysis for end-stage renal disease.

Study drug and study procedures will be made available to you at no cost.

To qualify, you must:

  • Be at least 18 years old undergoing chronic hemodialysis for end-stage renal disease three times a week

You will not qualify if you:

  • Are pregnant or breast-feeding
  • Have HIV
  • Have active infections
  • Have participated in a clinical drug or device trial within the last 30 days

To Learn more
Gender

Both Male and Female

Age

18 and up

Overall Status

Recruiting

Facility Type

N/A

Contact

Susan Mathew, Research Coordinator
Biomedical Research Alliance of New York
North Shore University Hospital
100 Community Drive - 2nd Floor
Great Neck, NY 11021
Phone: 516-465-8200

View Map

Research Center Information: Biomedical Research Alliance of New York

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 134393

Date Last Changed: July 25, 2013


DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.